SCD and neoplasm: SCD1 overexpression is observed in a multitude of aggressive malignancies [6-8], and targeted inhibition of this enzyme has been previously shown to impair tumor cell proliferation, and produce tumor-specific cellular stress and apoptosis in representative tumor models [6, 8].